Ductal carcinoma in situ is a precursor of breast cancer that is usually treated with surgery, radiation therapy, and estrogen blockade. A new study suggests that watchful waiting might be safe for so ...

Ductal carcinoma in situ (DCIS) is an early form of cancer confined to the lactiferous (milk producing) ducts of the breast. The choice of whether surgery is required or what surgery is best for you ...

Study reveals short term safety of active monitoring for ductal carcinoma in situ. ScienceDaily . Retrieved January 9, 2025 from www.sciencedaily.com / releases / 2024 / 12 / 241212115836.htm ...

Gina Gray, who was diagnosed with breast cancer in 2023, said fundraising has helped her get back to normal, after her ...

Key updates from SABCS 2024 in early breast cancer include the COMET study on DCIS recurrence, INSEMA trial on SLNB omission, and OlympiA updates on adjuvant olaparib, shared by Dr Harold Burstein.

Women with Stage 0 breast cancer who got biannual mammograms and delayed surgery for two years fared as well as those who got immediate surgery.

AI-supported mammography screening significantly increases breast cancer detection rates while maintaining comparable recall ...

One reporter is crediting actress Olivia Munn for saving her life. Inside Edition's Alison Hall shared an emotional post via ...

Each year, more than 56,500 women are diagnosed with ductal carcinoma in situ (DCIS), a non-invasive type of breast cancer commonly referred to as Stage 0 breast cancer. A woman with DCIS is ...

“All current treatments for DCIS aim to reduce the risk of future invasive cancer, despite a growing body of evidence that not all DCIS is destined to progress,” said Dr. Shelley Hwang, a professor of ...

The American Cancer Society projects 297,790 new cases of invasive breast cancer and 55,720 new cases of ductal carcinoma in situ (DCIS) this year. In all, 43,700 women are expected to lose their ...

SALT LAKE CITY, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced an agreement with Hannah Storm, a nationally ...